Skip to content

Asset turnover at other companies

Kymera Therapeutics logo
Kymera TherapeuticsKYMR
0.0×
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
0.1×-0.4×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
0.1×-0.5×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
0.1×+0.1×
Nuvation Bio logo
Nuvation BioNUVB
0.3×+0.2×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
0.5×+0.1×

Other financials

Income statement

See full
Revenue$6.3M-66.1%
Operating income-$92.5M-47.1%
Net income-$87.2M-54.7%
EPS (diluted)-$0.79-17.9%

Balance sheet

See full
Cash & equivalents$72.2M-6.1%
Total debt$58.7M+120%
Total equity$480.9M0.0%
Total assets$636.1M+3.4%

Cash flow

See full
Operating cash flow-$71.9M-17.7%
CapEx$1.0M-70.0%
Free cash flow-$73.0M-13.0%

Valuation

See full
Market cap$1.95B+40.1%
Enterprise value$1.94B+45.1%
P/S27.2×+2.5×

Profitability

See full
Operating margin-439.3%+35.3pp
Net margin-411.4%+52.7pp
FCF margin-378.7%+24.1pp

Returns & leverage

See full
Return on equity-61.4%-2.5pp
Debt / equity0.1×+0.1×
Current ratio-0.3×

Where this comes from

Calculated from Nurix Therapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s asset turnover?
Nurix Therapeutics, Inc. (NRIX) reported asset turnover of 0.1× in Q4 2025.
How has Nurix Therapeutics, Inc.'s asset turnover changed year-over-year?
Nurix Therapeutics, Inc.'s asset turnover decreased by 5.7% year-over-year, from 0.1× to 0.1×.
What is the long-term trend for Nurix Therapeutics, Inc.'s asset turnover?
Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s asset turnover has grown at a 8.9% compound annual growth rate (CAGR), from 0.1× to 0.1×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.